Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Israelsen GMP Tips: Watch “Wild Card” Law, Use CoA As Legal Documents

This article was originally published in The Tan Sheet

Executive Summary

Enforcement actions brought by the Federal Trade Commission against dietary ingredient companies that provide false or misleading certificates of analysis to supplement manufacturers could be an effective mechanism for assuring supply quality, according to Utah Natural Products Alliance Executive Director Loren Israelsen

You may also be interested in...



Supplement Industry Must Make United Response To NDI Guidance – AHPA

A united response from industry on the new dietary ingredient draft guidance could help prevent FDA from creating an even more burdensome policy, say representatives of the American Herbal Products Association.

Supplement Industry Must Make United Response To NDI Guidance – AHPA

A united response from industry on the new dietary ingredient draft guidance could help prevent FDA from creating an even more burdensome policy, say representatives of the American Herbal Products Association.

Supplement Industry Must Make United Response To NDI Guidance – AHPA

A united response from industry on the new dietary ingredient draft guidance could help prevent FDA from creating an even more burdensome policy, say representatives of the American Herbal Products Association.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS100955

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel